Podcasts about jama psychiatry

Without this one thing, every single thing you know and love would disappear. Soil would fail, forests would starve, antibiotics would, well, vanish, and your morning coffee, bread, beer, and even chocolate would be gone. The thing I'm talking about is everywhere. It's probably in your lunch. It's almost certainly in your lungs. It's in your sourdough starter, your compost heap. Got a clue yet? Most people don't actually know what these things are. I'm talking about fungi. Fungi are not plants, not animals, not bacteria — they're something else entirely. And they're really, really old.They're older than dinosaurs, older than sharks — they might even be older than plants, depending on how you define a plant.Today, I'm diving into something I'm actually violently allergic to: fungus. I'm covering everything from what fungi actually are (because it turns out most of us have no idea) to why they might be the most important thing on Earth… ish.In this episode I share: What prokaryotes and eukaryotes areWhat fungi actually areThe different types of fungiHow fungi moved from ocean to land and began a symbiotic relationship with plantsHow fungi can decompose almost anything — including radiationZombie fungus (and whether we should worry)How fungi reproduceWhy they're incredibly usefulSome of the annoying and dangerous things they doHow we might use fungi to help fix the planet.Key quotes:"Fungi are more closely related to us than to plants.""Turns out plants talk way more than you think they do."Sources: Billion-year-old fungal fossils (Nature 2019): https://www.nature.com/articles/s41586-019-1217-0Armillaria “humongous fungus” 9 km² individual: https://www.scientificamerican.com/article/strange-but-true-largest-organism-is-fungus/Prototaxites 8 m Silurian-Devonian giant: https://www.science.org/content/article/ancient-giant-fossils-may-be-world-s-oldest-known-terrestrial-fungi90 % of plants with mycorrhizae (Nature Scitable): https://www.nature.com/scitable/knowledge/library/an-ecological-and-evolutionary-perspective-on-mycorrhizal-24286790/Mycorrhizal carbon sink 3–7 Gt CO₂ yr⁻¹ (Science 2022): https://www.science.org/doi/10.1126/science.abf3457Penicillin discovery background (Nobel Prize): https://www.nobelprize.org/prizes/medicine/1945/fleming/facts/Statins from Penicillium citrinum (review): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958453/Cyclosporine discovery story: https://pubmed.ncbi.nlm.nih.gov/7568434/Psilocybin phase-II depression trial (JAMA Psychiatry 2021): https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2787297Plastic-eating fungus Pestalotiopsis microspora (2011 study): https://pubmed.ncbi.nlm.nih.gov/22269855/ CDC overview of Candida auris drug resistance: https://www.cdc.gov/fungal/candida-auris/Chytrid fungus amphibian decline paper (Science 2006): https://www.science.org/doi/10.1126/science.1125069Mycoremediation and mycofiltration review (Biodegradation 2018): https://link.springer.com/article/10.1007/s10532-018-0914-8Find our full podcast via the website here: https://www.nowthatswhaticall.com/Instagram: https://www.instagram.com/nowthatswhaticallgreen/You can follow me on socials on the below accounts.Instagram: https://www.instagram.com/briannemwest/TikTok: https://www.tiktok.com/@briannemwestLinkedIn: https://www.linkedin.com/in/briannemwest/

Contributor: Jorge Chalit-Hernandez, OMS3 Educational Pearls: Psychedelics are being studied for their therapeutic effects in mental illnesses, including major depressive disorder, post-traumatic stress disorder, anxiety, and many others Classic psychedelics include compounds like psilocybin, LSD, and ayahuasca MDMA and ketamine are often included in psychedelic research, but have a different mechanism of action than the others Their mechanism of action involves agonism of the 5HT2A receptor, among others Given their resurgence, there is an increase in recreational use of these substances A recent study assessed the risks of recreational users developing subsequent psychotic disorders Individuals who visited the ED for hallucinogen use had a greater risk of being diagnosed with a schizophrenia spectrum disorder in the following 3 years Hazard ratio (HR) of 21.32 After adjustment for comorbid substance use and other mental illness, the hazard ratio was 3.53 - still a significant increase compared with the general population They also found an elevated risk for psychedelics when compared to alcohol (HR 4.66) and cannabis (HR 1.47) The study did not assess whether patients received antipsychotics or other treatments in the ED References Lieberman JA. Back to the Future - The Therapeutic Potential of Psychedelic Drugs. N Engl J Med. 2021;384(15):1460-1461. doi:10.1056/NEJMe2102835 Livne O, Shmulewitz D, Walsh C, Hasin DS. Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP. Addiction. 2022;117(12):3099-3109. doi:10.1111/add.15987 Myran DT, Pugliese M, Xiao J, et al. Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder. JAMA Psychiatry. 2025;82(2):142-150. doi:10.1001/jamapsychiatry.2024.3532 Summarized & Edited by Jorge Chalit, OMS3 Donate: https://emergencymedicalminute.org/donate/  

Interview with Pim Cuijpers, PhD, author of Cognitive Behavior Therapy for Mental Disorders in Adults: A Unified Series of Meta-Analyses. Hosted by John Torous, MD Related Content: Cognitive Behavior Therapy for Mental Disorders in Adults

In episode 58 we discuss a randomized controlled trial of semaglutide for alcohol use disorder.    Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, Tow AC, Dermody SS, Prince MA, Jordan R, McKee SA, Fletcher PJ, Claus ED, Klein KR. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025 Feb 12:e244789.     We also discuss benzodiazepine tapering guidelines and new ways to use Sublocade.    ASAM Clinical Practice Guideline on Benzodiazepine Tapering  Sublocade label changes  ---  This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.  CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/  ---  Original theme music: composed and performed by Benjamin Kennedy  Audio editing: Michael Bonanno  Executive producer: Dr. Patrick Beeman  A podcast from Ars Longa Media  ---   This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.   The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.  Email: addictionmedicinejournalclub@gmail.com   Facebook: @AddictionMedJC  Facebook Group: Addiction Medicine Journal Club  Instagram: @AddictionMedJC   Threads: @AddictionMedJC  YouTube: addictionmedicinejournalclub   Twitter/X: @AddictionMedJC   Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Interview with Professor Jurgen Unutzer, MD, author of Effective Components of Collaborative Care for Depression in Primary Care: An Individual Participant Data Meta-Analysis. Hosted by John Torous, MD. Related Content: Effective Components of Collaborative Care for Depression in Primary Care

Welcome back to Authentically ADHD, where we explore the realities of living with ADHD—the science, struggles, and strengths. Host Carmen Irace delves into the debate of Consistency vs. Persistence, examining why one is more suited to ADHD brains than the other. This episode challenges conventional productivity wisdom and offers practical insights for sustainable success.The Expectation of Consistency: Consistency is often touted as key to success, yet for ADHD individuals, it can feel unattainable. Scientific insights reveal how ADHD brains navigate motivation and effort differently, highlighting the disconnect between traditional expectations and neurological reality.Redefining Success Through Persistence: Shifting focus to persistence, Irace explains why this approach aligns better with ADHD traits. Persistence allows for flexibility, embracing the natural ebb and flow of motivation without the guilt of perceived failures. Scientific studies underscore the effectiveness of this mindset in achieving long-term goals.Real-Life Examples of Persistence Over Consistency: Irace provides practical examples—from exercise routines to work productivity and relationships—illustrating how embracing persistence leads to sustained progress. Each scenario emphasizes adapting habits to individual rhythms rather than adhering to rigid schedules.How to Build Persistence (Without Pressure): The episode concludes with six science-backed strategies to cultivate persistence in daily life. These include leveraging micro-wins, using external structures like alarms and accountability partners, and fostering self-compassion to navigate setbacks effectively.Closing Thoughts: Consistency may be overrated, but persistence is ADHD-friendly and sustainable. Irace encourages listeners to embrace this mindset, emphasizing that success lies in resilience rather than unattainable perfection.This episode resonates with anyone who has struggled with maintaining routines or habits, offering a refreshing perspective that celebrates the unique strengths of ADHD. Join Carmen Irace next time as she continues to explore topics essential to thriving with ADHD.Link Tree: https://linktr.ee/carmen_iraceJoin Focused: https://ihaveadhdllc.ontralink.com/t?orid=29951&opid=1Show Notes:INTRODUCTIONHOST (Carmen Irace): Hey everyone! Welcome back to Authentically ADHD, the podcast where we dive deep into the realities of living with ADHD—the science, the struggles, and the strengths. I'm your host, Carmen Irace, and today, we're tackling a topic that I know so many of us wrestle with: Consistency vs. Persistence—and why one of these works way better for ADHD brains than the other.I want you to take a second and think about these two words. Consistency. Persistence. Which one makes you feel empowered? And which one makes you feel exhausted just thinking about it?For most of us with ADHD, "consistency" feels like this impossible standard that we just can't live up to. We're told that success comes from doing the same thing, the same way, over and over—but our brains just don't work that way. And that's okay.Today, we're breaking it all down. We'll explore:* The perception of these words and why consistency feels unattainable for ADHDers* The science behind why our brains struggle with consistency but thrive with persistence* Why persistence is actually the ADHD-friendly approach to long-term success* And some practical strategies to help you build persistence without pressureSo, if you've ever felt frustrated that you "can't stay consistent" with habits, work, or goals—this episode is for you. Let's jump in.THE EXPECTATION OF CONSISTENCYLet's start with consistency.This word is thrown around all the time in productivity culture:* “The key to success is consistency.”* “If you're not consistent, you're not disciplined.”* “Success comes from showing up every single day.”And if you have ADHD, hearing that feels like being asked to run a marathon with no training, no shoes, and no idea where the finish line is. Because consistency is built on predictability—and ADHD is the opposite of predictable.

In this episode Dr's J and Santhosh do a deep dive and chew the fat on the facts about ozempic, wegovy and the current crop of weight loss drugs. Along the way they cover gila monsters, synthetic insulins, lizard venom salesmen, ozempic and wegovy differences, cardioprotective and neuroprotective effects, ozempic pregnancies, addiction and reward treatment, kidney protection, prevention of brain shrinkage, alzheimers delay ozempic face and more! So sit back and relax as we cover the many faces of ozempic!Further ReadingJournal reference: JAMA Psychiatry DOI: 10.1001/jamapsychiatry.2024.4789https://www.nejm.org/doi/10.1056/NEJMoa2208601https://www.imperial.ac.uk/news/255214/weight-loss-drug-slow-alzheimers-decline/https://pubmed.ncbi.nlm.nih.gov/35180937/https://www.nature.com/articles/d41586-024-01564-whttps://www.nejm.org/doi/full/10.1056/NEJMoa2307563Support Us spiritually, emotionally or financially here! or on ACAST+travelmedicinepodcast.comBlueSky/Mastodon/X: @doctorjcomedy @toshyfroTikotok: DrjtoksmedicineGmail: travelmedicinepodcast@gmail.comSpotify: https://open.spotify.com/show/28uQe3cYGrTLhP6X0zyEhTPatreon: https://www.patreon.com/travelmedicinepodcast Supporting us monthly has all sorts of perks! You get ad free episodes, bonus musical parody, behind the scenes conversations not available to regular folks and more!! Your support helps us to pay for more guest interviews, better equipment, and behind the scenes people who know what they are doing! https://plus.acast.com/s/travelmedicinepodcast. Hosted on Acast. See acast.com/privacy for more information.

In a recent study published in JAMA Psychiatry, researchers reported that a machine learning model was able to stratify risk for subsequent diagnosis of schizophrenia or bipolar disorder among individuals already receiving psychiatric treatment. Coauthor Søren Dinesen Østergaard, PhD, of Aarhus University in Denmark joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss. Related Content: Machine Learning Model Shows Promise in Early Detection of Serious Mental Illness Predicting Diagnostic Progression to Schizophrenia or Bipolar Disorder via Machine Learning

Professor David Taylor is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at KCL. David is the Editor-in-Chief of the journal Therapeutic Advances in Psychopharmacology. Professor Taylor has been the lead author of the Maudsley Prescribing Guidelines since their inception in 1993. David has also authored over 375 clinical papers in journals such as the Lancet, BMJ, JAMA Psychiatry, British Journal of Psychiatry and Journal of Clinical Psychiatry. Today we discuss: - What the science says about the effectiveness of anti-depressants.- Evidence based principles for prescribing anti-depressants safely. - Common side effects and withdrawal symptoms. - Do anti-depressants work via so called "emotional numbing" effects?- The use of anti-depressants for other conditions such as OCD and PTSD. - Emerging treatments for depression such as ketamine and psilocybin. - New treatments for psychosis such as KarXT (Cobenfy). Interviewed by Dr. Alex Curmi. Dr. Alex is a consultant psychiatrist and a UKCP registered psychotherapist in-training.If you would like to invite Alex to speak at your organisation please email alexcurmitherapy@gmail.com with "Speaking Enquiry" in the subject line.Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - alexcurmitherapy@gmail.com with "Coaching" in the subject line.Give feedback here - thinkingmindpodcast@gmail.com - Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast Tiktok - @thinking.mind.podcast 

Interview with Srividya N. Iyer, PhD, author of An Approach to Providing Timely Mental Health Services to Diverse Youth Populations. Hosted by John Torous, MD. Related Content: An Approach to Providing Timely Mental Health Services to Diverse Youth Populations

Lifting the Cloud: Transcranial Magnetic Stimulation and the Treatment of Major DepressionThis episode provides an in-depth exploration of Transcranial Magnetic Stimulation (TMS) and its impact on psychiatric disorders.  TMS has demonstrated effectiveness in numerous clinical trials and serves as a valuable adjunct to traditional therapy. Designed for clinicians and mental health professionals and those they serve, this podcast offers insights into:Identifying appropriate patient populations for TMS therapy.  Understanding the TMS treatment process from start to finish.  Exploring the role of neuromodulation in reshaping brain function for long-term improvement.  Reviewing clinical outcome data supporting TMS in the treatment of major depressive disorder.  Gain a deeper understanding of how TMS and neuromodulation techniques are advancing the field of functional neuropsychiatry and providing new hope for patients. Objectives: Identify appropriate patient populations for Transcranial Magnetic Stimulation (TMS) treatment of psychiatric disorders.Describe the treatment process of Transcranial Magnetic Stimulation. Describe possible adverse events associated with Transcranial Magnetic Stimulation.Explain how neuromodulation techniques impact long-term changes in brain network functioning.Discuss clinical outcome data for Transcranial Magnetic Stimulation treatment. Guests: Dr. Henry Emerle, MDDr. Rich Whitaker, PhDBios: Dr. Rich Whitaker began his career in the Quad Cities in 1994 as a doctoral intern at the historic Marriage and Family Counseling Service in Rock Island, Illinois as part of his Ph.D. in Marriage and Family Therapy from Brigham Young University. Since that pivotal year, Dr. Whitaker has pursued a career in community mental health, providing services, supervision, and executive administration at community mental health centers in Grand Island, Nebraska (9 years as COO) and Jasper, Indiana (12 years as CFO). Since January 2017, Rich has served as the CEO of Vera French Community Mental Health Center in Davenport, Iowa.  In addition to serving as a Director of Region 7 on the Board of the National Council for Mental Wellbeing, Dr. Whitaker also serves as a Government Relations Committee member for the Iowa Association of Community Providers, as a Board member of Churches United in the Quad Cities, and as a member of the Eastern Iowa MHDS Regional Advisory Committee.Rich and Miriam are the parents of 3 daughters and one son and the proud grandparents of a growing number of highly intelligent and multi-talented grandchildren. In his spare time, Rich enjoys family time, all types of sports and exercise, singing with the Quad City Singers, and service in the church and community.Henry Emerle, MD completed his medical school training at the University of Illinois College of Medicine at Urbana-Champaign, IL.  He completed Psychiatry Residency training as well as Geriatric Psychiatry Fellowship training at the University of Michigan in Ann Arbor, MI. He is the Medical Director at Vera French Community Mental Health Center.   He enjoys spending time with his family exploring the many charming towns in Iowa along the Mississippi River. References: Cash RFH, Cocchi L, Lv J, Fitzgerald PB, Zalesky A. Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression. JAMA Psychiatry. 2021;78(3):337–339. doi:10.1001/jamapsychiatry.2020.3794Jannati, A., Oberman, L.M., Rotenberg, A. et al. Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation. Neuropsychopharmacol. 48, 191–208 (2023). https://doi.org/10.1038/s41386-022-01453-8Pitcher, D., Parkin, B., & Walsh, V. (2021). Transcranial magnetic stimulation and the understanding of behavior. Annual Review of Psychology, 72, 97-121. https://doi.org/10.1146/annurev-psych-081120-013144Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study (n.d.) https://www.nimh.nih.gov/funding/clinical-research/practical/stard

Measles cases are rising in Texas and New Mexico, with most infections occurring in unvaccinated individuals and public health officials warning of further spread. A new study in JAMA Psychiatry found that semaglutide significantly reduces alcohol craving and heavy drinking, suggesting a potential new treatment for alcohol use disorder. Research confirms that self-sampling for HPV is as effective as speculum-based exams, improving accessibility for women with disabilities and underserved populations. With the FDA's recent approval, self-collection could revolutionize cervical cancer screening in the U.S.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novo's semaglutide shows promise in curbing alcohol use disorder, according to data published in JAMA Psychiatry. This supports the use of GLP-1 receptor agonists for addictive disorders. Meanwhile, the Trump administration is considering job cuts at the FDA. This could potentially lead to uncertainty and delays in regulatory reviews.In other news, Sanofi is facing a $250 million impairment after scrapping a J&J-partnered E. coli vaccine. Roche's Evrysdi has become the first pill cleared for spinal muscular atrophy. Pfizer has expanded the label for Adcetris to include non-Hodgkin lymphomas.Additionally, Newleos Therapeutics has raised $93.5 million to advance neuropsychiatric drugs from Roche's pipeline. All this information was shared by BioSpace, a platform that provides updates on the biotech and pharmaceutical industry.

Un nouvel épisode du Pharmascope est disponible… Et on aborde encore l'andropause et son traitement! Dans cette deuxième partie, Nicolas, Isabelle et Olivier discutent des données d'efficacité et d'innocuité de la testostérone en contexte d'andropause. Les objectifs pour cet épisode sont les suivants: Discuter de la prise en charge pharmacologique de l'andropause Discuter des données d'efficacité de la testostérone en contexte d'andropause Discuter des données d'innocuité de la testostérone en contexte d'andropause Ressources pertinentes en lien avec l'épisode  Série documentaire « L'andropause sans tabou ». Disponible sur l'EXTRA d'ICI TOU.TV TTrialsSnyder PJ, et coll.; Testosterone Trials Investigators. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016 Feb 18;374(7):611-24. Resnick SM, et coll. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment. JAMA. 2017 Feb 21;317(7):717-727. Roy CN, et coll. Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial. JAMA Intern Med. 2017 Apr 1;177(4):480-490. TRAVERSELincoff AM, et coll; TRAVERSE Study Investigators. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 Jul 13;389(2):107-117. Pencina KM, et coll. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. J Clin Endocrinol Metab. 2024 Jan 18;109(2):569-580. Bhasin S, et coll. Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy. J Clin Endocrinol Metab. 2024 Jun 17;109(7):1814-1826. Pencina KM, et coll. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 Oct 2;6(10):e2340030. Snyder PJ, Bauer DC, Ellenberg SS, Cauley JA, Buhr KA, Bhasin S, Miller MG, Khan NS, Li X, Nissen SE. Testosterone Treatment and Fractures in Men with Hypogonadism. N Engl J Med. 2024 Jan 18;390(3):203-211. Autres référencesLee H, et coll. Testosterone replacement in men with sexual dysfunction. Cochrane Database Syst Rev. 2024 Jan 15;1(1):CD013071. Domes T, et coll. Canadian Urological Association guideline: Erectile dysfunction. Can Urol Assoc J. 2021 Oct;15(10):310-322. Buvat J, et coll. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). J Sex Med. 2011 Jan;8(1):284-93. Walther A, Breidenstein J, Miller R. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2019 Jan 1;76(1):31-40. Wittert G, et coll. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol. 2021 Jan;9(1):32-45. Bhasin S, et coll. Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial. JAMA Intern Med. 2024 Apr 1;184(4):353-362.

What are psychedelics? How do they impact your brain? Are they safe? Parker and Emma unpack the current research and legality of psychedelics and discuss the ethical implications of psychoactive drugs. Sources: Cheung, K., Earp, B. D., Patch, K., & Yaden, D. B. (2025). Distinctive But Not Exceptional: The Risks of Psychedelic Ethical Exceptionalism. The American Journal of Bioethics, 25(1), 16–28. Tiwari, P., Davoudian, P. A., Kapri, D., Vuruputuri, R. M., Karaba, L. A., Sharma, M., … Vaidya, V. A. (2024). Ventral hippocampal parvalbumin interneurons gate the acute anxiolytic action of the serotonergic psychedelic DOI. Neuron, 112(22), 3697-3714. Wang, E., Mathai, D. S., Gukasyan, N., Nayak, S., & Garcia-Romeu, A. (2024). Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. Healthcare Professionals. Scientific Reports, 14(1), 28022. Davis, A. K., Bates, M., Lund, E. M., Sepeda, N. D., Levin, A. W., Armstrong, S. B., … Yehuda, R. (2024). The Epidemiology of Psychedelic Use Among United States Military Veterans. Journal of Psychoactive Drugs, 1–14. Published Online. September 12, 2024. Ehrenkranz, R., Agrawal, M., Nayak, S. M., & Yaden, D. B. (2024). Adverse events should not be surprising in psychedelic research. Psychedelic Medicine. Published Online. September 4, 2024. Hinkle, J. T., Graziosi, M., Nayak, S. M., & Yaden, D. B. (2024). Adverse events in studies of classic psychedelics. JAMA Psychiatry, 81(12), 1225-1235. Yaden, D. B., Goldy, S. P., Weiss, B., & Griffiths, R. R. (2024). Clinically relevant acute subjective effects of psychedelics beyond mystical experience. Nature Reviews Psychology, 3(9), 606–621. Goldy, S. P., Hendricks, P. S., Keltner, D., & Yaden, D. B. (2024). Considering distinct positive emotions in psychedelic science. International Review of Psychiatry, 1–12. Published Online. September 2, 2024. Heller, N. H. & Barrett, F. S. (2024). Teaching a new dog old tricks: bringing rigor, grounding, and specificity to psychedelic neuropsychopharmacology. Neuropsychopharmacology. Published Online. August 26, 2024. Yaden, D. B., Mathai, D., Bogenschutz, M., & Nichols, D. E. (2024). The pharmacology of hallucinogens. In: Miller et al. (Eds.). Principles of Addiction Medicine. American Society of Addiction Medicine. Yaden, D. B., Nayak, S. M., Griffiths, R. R. (2024). Belief change and agnostic frames in psychedelic research and clinical contexts. In: C. Letheby (Ed.). Philosophy and the psychedelic renaissance. Oxford University Press, New York. DiRenzo, D., Barrett, F. S., Perin, J., Darrah, E., Christopher-Stine, L., & Griffiths, R. R. (2024). Impact of psilocybin on peripheral cytokine production. Psychedelic Medicine, 2(2). Cheung, K., Propes, C., Jacobs, E., Earp, B. D., & Yaden, D. B. (2024). Psychedelic group-based integration: Ethical assessment and initial recommendations. International Review of Psychiatry, 1–11. Tiwari, P., Ehrenkranz, R., & Yaden, D. B. (2024). Psychiatric Applications of Psychedelics: Neurobiological Foundations for Treatments of Depression, Anxiety, and Obsessive-Compulsive Disorder. Advances in Psychiatry and Behavioral Health. McGuire, A. L., Cohen, I. G., Sisti, D., Baggott, M., Celidwen, Y., Devenot, N., Gracias, S., Grob, C., Harvey, I., Kious, B., Marks, M., Mithoefer, M., Nielson, E., Öngür, D., Pallas, A., Peterson, A., Schenberg, E. E., Summergrad, P., Waters, B., Williams, M. T., & Yaden, D. B. (2024). Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement. JAMA Network Open, 7(6), e2414650.

Interview with Jonathan Cantor, PhD, author of Changes in Specialty Crisis Services Offered Before and After the Launch of the 988 Suicide and Crisis Lifeline. Hosted by John Torous, MD. Related Content: Changes in Specialty Crisis Services Offered Before and After the Launch of the 988 Suicide and Crisis Lifeline

In recent years, cannabis has been celebrated for its therapeutic potential, including pain relief, anxiety management, and even its role in reducing seizures. But behind the rising popularity lies a growing concern: its impact on young minds at risk of psychosis. A groundbreaking study conducted at McGill University, recently published in JAMA Psychiatry, sheds light on how cannabis exacerbates brain changes in young adults already vulnerable to psychosis. For some, this is not just a scientific finding—it's a lived nightmare.

Interview with Jayani Jayawardhana, PhD, author of Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning. Hosted by John Torous, MD, MBI. Related Content: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-409 Overview: Listen in as we discuss how bright light therapy extends beyond seasonal affective disorder, potentially offering benefits for nonseasonal depression. Learn how to counsel patients effectively on its use and integrate this treatment into your practice, enhancing patient care and broadening treatment strategies for depression. Episode resource links: Menegaz de Almeida A, Aquino de Moraes FC, Cavalcanti Souza ME, Cavalcanti Orestes Cardoso JH, Tamashiro F, Miranda C, Fernandes L, Kreuz M, Alves Kelly F. Bright Light Therapy for Nonseasonal Depressive Disorders: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2024 Oct 2:e242871  Guest: Alan M. Ehrlich, MD, FAAFP   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com   

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-409 Overview: Listen in as we discuss how bright light therapy extends beyond seasonal affective disorder, potentially offering benefits for nonseasonal depression. Learn how to counsel patients effectively on its use and integrate this treatment into your practice, enhancing patient care and broadening treatment strategies for depression. Episode resource links: Menegaz de Almeida A, Aquino de Moraes FC, Cavalcanti Souza ME, Cavalcanti Orestes Cardoso JH, Tamashiro F, Miranda C, Fernandes L, Kreuz M, Alves Kelly F. Bright Light Therapy for Nonseasonal Depressive Disorders: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2024 Oct 2:e242871  Guest: Alan M. Ehrlich, MD, FAAFP   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com   

Interview with Daniel T. Myran, MD, MPH, author of Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder. Hosted by John Torous, MD. Related Content: Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder

Interview with Benoit H. Mulsant, MD, MS, and Tarek K. Rajji, MD, authors of Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial. Hosted by John Torous, MD, MBI. Related Content: Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment

In this episode, we're exploring the various ways stress affects your brain, both positively and negatively.We'll discuss the key differences between eustress (the beneficial kind) and distress (the harmful kind), and reveal practical strategies to manage chronic stress for better cognitive health.Whether you're dealing with daily pressures or long-term stress, this episode will arm you with knowledge to protect your brain and help you build resilience.What to Listen For:The key differences between eustress (positive stress) and distress (chronic stress).How chronic stress leads to memory loss, emotional difficulties, and increased Alzheimer's risk.The role of cortisol and the HPA axis in stress responses and brain health.How eustress boosts cognitive function, memory, and neuroplasticity.The dangers of prolonged cortisol exposure on brain structures like the hippocampus and amygdala.A study from Frontiers in Behavioral Neuroscience showing how moderate stress improves learning and memory.How chronic stress can trigger brain inflammation and accelerate cognitive decline.Practical strategies for reducing chronic stress: mindfulness meditation, social connections, and reframing stress as a positive force.The effects of chronic stress on the amygdala, prefrontal cortex, and hippocampus.Three actionable tips to protect your brain from the long-term effects of stress.Research Studies Referenced:McEwen BS (2007). "Physiology and neurobiology of stress and adaptation: central role of the brain." Physiol Rev, 87(3), 873-904. This paper explores how stress affects brain function and structure.Lupien SJ, et al. (2009). "Effects of stress throughout the lifespan on the brain, behaviour and cognition." Nat Rev Neurosci, 10(6), 434-445.Sousa N, et al. (2016). "Cortical and hippocampal circuitry changes under chronic stress: Implications for mood and cognition." Prog Neuropsychopharmacol Biol Psychiatry, 67, 1-14.Wilson, R. S., et al. (2007). "Chronic distress and incidence of mild cognitive impairment." JAMA Psychiatry, 68(2), 211-218Tang YY, et al. (2015). "The neuroscience of mindfulness meditation." Nat Rev Neurosci, 16(4), 213-225.RESOURCES: Access the FREE Masterclass: How To Optimize Your Sleep Order Amy's book Thoughts Are Habits Too: Master Your Triggers, Free Yourself From Diet Culture, and Rediscover Joyful Eating. Join our private Facebook group: Moxie Club Meetup Follow Amy on Instagram @habitwhisperer

This episode of the Ketamine Startup Podcast, comes from a presentation Sam gave at the American College of Emergency Physicians Scientific Assembly on October 1, 2024. Discover the journey of opening a ketamine clinic, the efficacy of IV ketamine for depression, anxiety, PTSD, and chronic pain, and the mechanism behind its success. You will learn about the growing mental health crisis, high burnout rates among emergency physicians, and why ketamine therapy can be a rewarding alternative career path. Sam also shares the emotional and financial realities of running a ketamine clinic, emphasizing the importance of motivation, purpose, and personal fulfillment. Hear powerful testimonials from patients and gain practical advice for starting your own clinic. Don't miss this comprehensive guide filled with scientific studies, real-life experiences, and expert insights.What You'll Learn In This Episode:• Career Transition: Discover how emergency physicians can pivot into running ketamine clinics and find greater autonomy and purpose.• Clinical Evidence: Explore key studies supporting the use of ketamine therapy for depression, anxiety, PTSD, and chronic pain.• Overcoming Challenges: Understand the financial and emotional challenges of running a ketamine clinic and how to stay motivated by focusing on your "why."Episode 22 show notes:00:00 Teaser - The Swimming Pool Dilemma00:35 Introduction01:10 Sam's Journey and Niche in Ketamine Therapy03:12 The Mental Health Crisis05:05 Challenges Faced by Emergency Physicians06:13 Scientific Studies on IV Ketamine Therapy08:45 Ketamine for Anxiety and PTSD10:47 Ketamine for Chronic Pain12:13 How Does Ketamine Work?12:17 Ketamine's Impact on Neurotransmitters13:11 Ketamine and Chronic Stress14:06 Hallucinogenic Effects of Ketamine14:57 Emergency Medicine and Ketamine16:16 Starting a Ketamine Clinic17:19 The Importance of Your 'Why'18:33 Challenges and Rewards of a Ketamine Clinic20:12 Patient Testimonials and Impact21:34 ConclusionThanks for listening

Interview with David B. Yaden, PhD, and Jared T. Hinkle, MD, PhD, authors of Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD, MBI. Related Content: Adverse Events in Studies of Classic Psychedelics

In this interview for MIA Radio, Brooke Siem speaks with David Taylor and Mark Horowitz about their publication of the Maudsley Deprescribing Guidelines, which is of particular note since the Maudsley Prescribing Guidelines is a leading text in medicine worldwide. David Taylor is the Director of Pharmacy and Pathology at Maudsley Hospital and a Professor of Psychopharmacology at King's College in London. He is also the editor-in-chief of the journal Therapeutic Advances in Psychopharmacology. Beyond academia, he contributes significantly to public health policy as a member of the United Kingdom's Department of Transport expert panel that introduced drug-driving regulations. He is also a current member of the UK government's Advisory Council on the Misuse of Drugs and is the only pharmacist to have been made an honorary fellow of the Royal College of Psychiatrists. David is the lead author of the Maudsley Prescribing Guidelines, a role he has held since their inception in 1993. The Maudsley Prescribing Guidelines have achieved significant success, with over 300,000 copies sold across 14 editions and translations into 12 languages. David has also authored 450 clinical papers published in prominent journals such as The Lancet, BMJ, British Journal of Psychiatry, and Journal of Clinical Psychiatry. His work has been cited over 25,000 times. Mark Horowitz is a clinical research fellow in psychiatry at the National Health Service (NHS) in London. He is a Visiting Lecturer in Psychopharmacology at King's College London and an Honorary Clinical Research Fellow at University College London, in addition to being a trainee psychiatrist. Mark holds a PhD from the Institute of Psychiatry, Psychology, and Neuroscience at King's College London, specializing in the neurobiology of depression and antidepressant action. He is the lead author of the Maudsley Deprescribing Guidelines and an associate editor of Therapeutic Advances in Psychopharmacology. Mark co-authored the recent Royal College of Psychiatry's guidance on stopping antidepressants, and his work has informed the recent NICE guidelines on the safe tapering of psychiatric medications, including antidepressants, benzodiazepines, and z-drugs. He has collaborated with the NHS to develop national guidance for safe deprescribing for clinicians and has been commissioned by Health Education England to prepare a teaching module on how to safely stop antidepressants. Mark has published several papers on safe approaches to tapering psychiatric medications, with contributions in The Lancet Psychiatry, JAMA Psychiatry, and Schizophrenia Bulletin. His interest lies in rational psychopharmacology and the deprescribing of psychiatric medications, which is deeply informed by his personal experiences of the challenges associated with coming off psychiatric medications. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2024. Produced by James Moore https://www.jmaudio.org

Interview with Jonathan A. C. Sterne, PhD, author of COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People. Hosted by John Torous, MD. Related Content: COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People

Interview with Robert D. Gibbons, PhD, and Ronald C. Kessler, PhD, authors of Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders. Hosted by John Torous, MD, MBI. Related Content: Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders

Se coucher tard a des effets significatifs sur le cerveau, comme le démontrent plusieurs études scientifiques. Une étude publiée dans Nature en 2017 a montré que les individus qui dorment moins de six heures par nuit ont une performance cognitive réduite, notamment en termes de mémoire, d'attention et de prise de décision. Les chercheurs ont observé une diminution de la matière grise dans les régions du cerveau associées à ces fonctions chez les personnes chroniquement privées de sommeil.En 2019, une étude dans JAMA Psychiatry a révélé que les adolescents qui se couchaient après minuit avaient un risque accru de développer des symptômes dépressifs. L'étude, portant sur 4 175 adolescents, a trouvé que chaque heure de coucher tardive augmentait de 38% le risque de symptômes dépressifs et de 23% celui de pensées suicidaires.De plus, une étude de l'université de Stanford a souligné que se coucher tard perturbe le rythme circadien, provoquant un désalignement entre l'horloge interne et les cycles naturels de lumière et d'obscurité. Cela peut entraîner une dysrégulation de la sécrétion de mélatonine, une hormone cruciale pour le sommeil. Un mauvais alignement du rythme circadien a été associé à des troubles de l'humeur, notamment la dépression et l'anxiété.Des données de la UK Biobank, portant sur 91 000 participants, ont montré que les individus qui se couchaient après 23 heures avaient un risque 25% plus élevé de développer des troubles cognitifs et de l'humeur par rapport à ceux qui se couchaient plus tôt. Ces effets sont exacerbés par la lumière bleue des écrans, qui inhibe la production de mélatonine et perturbe le sommeil.Une autre recherche publiée dans Sleep en 2020 a révélé que les personnes qui se couchent tard sont plus susceptibles de souffrir de troubles de la régulation émotionnelle, ce qui peut entraîner une augmentation des comportements impulsifs et des difficultés à gérer le stress.Mais alors quelle est l'heure maximale à laquelle faut-il aller au lit pour préserver sa santé mentale ?Les chercheurs ont analysé les données de 73 888 adultes, âgés en moyenne de 63,5 ans, issus de la UK Biobank. Les participants ont fourni des informations sur leurs habitudes de sommeil et ont porté un moniteur d'activité pendant une semaine. Les résultats montrent que plus de 19 000 participants étaient des "couche-tôt", plus de 6 800 des "couche-tard", et près de 48 000 se situaient entre les deux.Les données de sommeil ont été comparées aux dossiers médicaux des participants, révélant que se coucher tard est associé à des taux plus élevés de troubles mentaux et comportementaux. Ceux qui se couchaient tard, qu'ils soient du matin ou du soir, avaient des taux plus élevés de dépression et d'anxiété.Les conclusions de l'étude indiquent qu'il convient de se coucher avant une heure du matin pour préserver la santé mentale, soulignant que les comportements nuisibles, comme les pensées suicidaires, la consommation d'alcool et de drogues, et la suralimentation, sont plus fréquents la nuit. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Powered by Firstory Hosting

Birth control at Ralphs? (1:09) 2 years after Roe v Wade was overturned – lives that have been saved.  (19:32) Miracles! (37:07) Is your phone your bedtime friend? (43:04)      Resources mentioned :  Birth control over the counter https://relevantradio.com/2024/03/loud-budgeting-ditching-the-pill/   Birth control studies:  Opill product label warnings https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017031s035s036lbl.pdf    2023 UK Study: Fitzpatrick D, Pirie K, Reeves G, Green J, Beral V (2023) Combined and progestogen-only hormonal contraceptives and breast cancer risk: A UK nested case–control study and meta-analysis. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004188    Study Linking Birth Control to Depression and anxiety  research, published in JAMA Psychiatry: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2552796    2015 study Hormonal contraceptive use and risk of glioma https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386952/#:~:text=WHAT%20THIS%20STUDY%20ADDS,term%20users%20of%20hormonal%20contraceptives    2016 study The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer https://pubmed.ncbi.nlm.nih.gov/26808155/   Study 10% of women who conceive in Opill/ progesterone only pill have Ectopic Pregnancies  https://www.ncbi.nlm.nih.gov/books/NBK539860/     Layla Khlan had a blood clot in her brain from birth control and died https://www.eviemagazine.com/post/girl-16-dies-after-taking-birth-control-pill-ease-painful-periods   Birth control makes women sad JAMA study  https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2552796   Tik Tok Stories about coming off the pill  https://www.tiktok.com/@katesnooks/video/7274529764055010593?embed_source=71929435%2C121374463%2C121404359%2C121351166%2C121331973%2C120811592%2C120810756%3Bnull%3Bembed_blank&refer=embed&referer_url=www.eviemagazine.com%2Fpost%2Fyoung-women-are-turning-against-the-pill-here-is-why&referer_video_id=7274529764055010593   Hair loss: https://www.tiktok.com/@chan.sessions?referer_url=www.eviemagazine.com%2Fpost%2Fyoung-women-are-turning-against-the-pill-here-is-why&refer=embed&embed_source=71929435%2C121374463%2C121404359%2C121351166%2C121331973%2C120811592%2C120810756%3Bnull%3Bembed_name&referer_video_id=7093254780230962478   Birth control makes women sad JAMA study  https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2552796   Hailey Bieber had a stroke from birth control https://relevantradio.com/2022/05/why-did-hailey-bieber-have-a-stroke/   Vox Vitae's website https://www.voxvitae.org/   Dr. Caldwell's episodes about IVF and fertility help  https://relevantradio.com/?cat=23210&s=susan+caldwell

Interview with Vadim Zipunnikov, PhD, author of Integrative Modeling of Accelerometry-Derived Sleep, Physical Activity, and Circadian Rhythm Domains With Current or Remitted Major Depression. Hosted by John Torous, MD, MBI. Related Content: Integrative Modeling of Accelerometry-Derived Sleep, Physical Activity, and Circadian Rhythm Domains With Current or Remitted Major Depression

Interview with Tom Bschor, MD, author of Differential Outcomes of Placebo Treatment Across 9 Psychiatric Disorders: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD, MBI. Related Content: Differential Outcomes of Placebo Treatment Across 9 Psychiatric Disorders

A February 2024 research review in JAMA Psychiatry identified perinatal mental health and substance use disorders, namely suicide and opioid...[…]

A February 2024 research review in JAMA Psychiatry identified perinatal mental health and substance use disorders, namely suicide and opioid...[…]

The latest medical data on birth control – ingredient progestin causes cancer. Pam Stenzel, the Client Services Director for 5 pregnancy resource centers, joins Trending with Timmerie. (6:05) What's the most common type of abortion?  How are women harmed by chemical abortion? (6:48) Dating trends and women falling in love with AI boyfriends. One woman's engagement ended because of her AI affair.    Resources mentioned:  Birth control over the counterhttps://relevantradio.com/2024/03/loud-budgeting-ditching-the-pill/ Contraception studies: 2023 UK Study: Fitzpatrick D, Pirie K, Reeves G, Green J, Beral V (2023) Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case–control study and meta-analysis. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004188  Study Linking Birth Control to Depression and anxiety research, published in JAMA Psychiatry:https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2552796  Video explaining 1st trimester chemical abortion: https://www.youtube.com/watch?v=gnEHZiud8dg SCOTUS Abortion case explained: https://relevantradio.com/2023/12/scotus-to-hear-chemical-abortion-case/ Pam Stenzel's Website:http://pamstenzel.net/  Florida Community Pregnancy Clinics:https://supportcpci.com/ Support After Abortion Website: https://supportafterabortion.com/    More birth control research: 2015 study Hormonal contraceptive use and risk of gliomahttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386952/#:~:text=WHAT%20THIS%20STUDY%20ADDS,term%20users%20of%20hormonal%20contraceptives  2016 study The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer:https://pubmed.ncbi.nlm.nih.gov/26808155/ Study 10% of women who conceive in Opill/ progesterone only pill have Ectopic Pregnancies: https://www.ncbi.nlm.nih.gov/books/NBK539860/ Opill product label warnings:https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017031s035s036lbl.pdf  Layla Khlan had a blood clot in her brain from birth control and died:https://www.eviemagazine.com/post/girl-16-dies-after-taking-birth-control-pill-ease-painful-periods Birth control makes women sad JAMA study: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2552796 Tik Tok Stories about coming off the pill:https://www.tiktok.com/@katesnooks/video/7274529764055010593?embed_source=71929435%2C121374463%2C121404359%2C121351166%2C121331973%2C120811592%2C120810756%3Bnull%3Bembed_blank&refer=embed&referer_url=www.eviemagazine.com%2Fpost%2Fyoung-women-are-turning-against-the-pill-here-is-why&referer_video_id=7274529764055010593 Hair loss: https://www.tiktok.com/@chan.sessions?referer_url=www.eviemagazine.com%2Fpost%2Fyoung-women-are-turning-against-the-pill-here-is-why&refer=embed&embed_source=71929435%2C121374463%2C121404359%2C121351166%2C121331973%2C120811592%2C120810756%3Bnull%3Bembed_name&referer_video_id=7093254780230962478 Birth control makes women sad JAMA study: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2552796 Hailey Bieber had a stroke from birth control:https://relevantradio.com/2022/05/why-did-hailey-bieber-have-a-stroke/

Scientific studies  support the benefits of mindful movement. For instance, a study published in the Journal of Clinical Psychology found that regular exercise can be as effective as medication for reducing symptoms of depression and anxiety. Another study published in the journal Frontiers in Psychology found that mindfulness-based movement practices like yoga and Tai Chi can improve mood, reduce stress, and increase overall well-being.In fact, a meta-analysis published in JAMA Psychiatry found that exercise has a large and significant effect on reducing symptoms of depression, regardless of the intensity or duration of the activity. The researchers analyzed 49 studies involving nearly 267,000 participants and found that exercise was associated with a 17% reduction in the risk of developing depression.But how can we incorporate mindful movement into our busy daily lives?Tune into this episode where Noa shares 4 easy steps you can take today to rewire your brain and make movement and new habits part of your daily wellness  routine.Sign up to Noa's NEW 360 Wellness course and receive a 15% coupon code when you mention Raising the New Earth Podcast! Click the link here: https://naturallynoa.com/coursesWe thrive in community - and we'd love you to be part of ours!Join the conversation @raisingthenewearth on IG , YouTube- or all other podcast platforms and learn more at www.raisingthenewearth.comDISCLAIMER: By watching/listening to this post including but not limited to video, text, reel, audio, (“Post”) you understand and agree to the following: This Post is for General information purposes ONLY. We are not liable for any loss, death, property damage, or bodily injury, based on your use or interpretation of the information in this Post. This Post should not be construed as a promise of benefits, a claim of cures, or a guarantee of results to be achieved.

A new study suggests that teenagers who spend too much on computers and video games may turn psychotic. A new paper published in JAMA Psychiatry says researchers studied over 12-hundred participants who spent a lot of time online as teenagers and found they were up to seven percent more likely than their peers to have a psychotic experience, such as delusions or hallucinations, before age 23. We did a deeper dive into the specifics of this and highlighting some key points to the study that make it less scary, with Dr. Fred Browne of Griffin Health. Image Credit: Eric Urbanowicz

Interview with Vincent Paquin, MD, and Jai L. Shah, MD, MSc, authors of Trajectories of Adolescent Media Use and Their Associations With Psychotic Experiences. Hosted by John Torous, MD, MBI. Related Content: Trajectories of Adolescent Media Use and Their Associations With Psychotic Experiences

Dr. Angela Rufo reviews two articles exploring the connection between mental health and exercise on this episode of the Top Sports Medicine Articles podcast, which is hosted by Dr. Jeremy Schroeder. The first article is the #11 of 2022 and asks the question, “Can High-intensity Interval Training Improve Mental Health Outcomes in the General Population and Those with Physical Illnesses?” It was originally published in the British Journal of Sports Medicine in February 2022. The second article was selected as the #9 of 2022, examining the “Association Between Physical Activity and Risk of Depression,” which was originally published in JAMA Psychiatry in April 2022. Dr. Rufo is a member of the AMSSM Top Articles Subcommittee, and this episode is part of an ongoing mini journal club series highlighting each of the Top Articles in Sports Medicine from 2022, as selected for the 2023 AMSSM Annual Meeting in Phoenix, AZ.   Can High-intensity Interval Training Improve Mental Health Outcomes in the General Population and Those with Physical Illnesses? A Systematic Review and Meta-analysis DOI: doi.org/10.1136/bjsports-2021-103984 Association Between Physical Activity and Risk of Depression: A Systematic Review and Meta-analysis DOI: 10.1001/jamapsychiatry.2022.0609

Interview with Otto Simonsson, PhD, author of Adolescent Psychedelic Use and Psychotic or Manic Symptoms. Hosted by John Torous, MD, MBI. Related Content: Adolescent Psychedelic Use and Psychotic or Manic Symptoms

Download my free guided meditation audio bundle here: https://thewellnessengineer.com/audiobundle   Protect yourself from harmful EMFs with the Harmoni Pendant. Save up to 50% on Harmoni Pendant here: https://thewellnessengineer.com/harmoni   Did you know the nocebo effect is the phenomenon where a person experiences adverse effects or worsening symptoms after receiving an inactive substance or treatment simply because they expect it to be harmful? It is essentially the opposite of the placebo effect, where a person experiences improvements in their condition due to believing in the effectiveness of a treatment, even if it is inert. In the case of the nocebo effect, negative expectations can lead to real physiological or psychological effects, often complicating medical treatments and clinical trials. Join me and my guest, Dr. Cosima Locher, Ph.D., to learn more about the book "The Nocebo Effect, When Words Make You Sick," which is the first book to investigate this fascinating phenomenon and offers a wide variety of topics and angles by the foremost researchers in this emerging field.   In this episode you'll learn: ⏰ 00:00 - Intro ⏰ 04:34 - Nocebo Effect Mechanisms ⏰ 12:12 - Empowerment in the Nocebo Effect ⏰ 20:50 - Sources of Chronic Pain ⏰ 28:33 - The Book Dr. Cosima Co-Authored ⏰ 35:59 - The ONE Thing You Can Do Today   Listen to Wellness By Design on the go with these apps: Apple Podcasts Spotify iHeart Radio Subscribe, rate and review!   Check out Dr. Cosima Locher, Ph.D.'s Bio: Cosima Locher, Ph.D., is a psychologist who is dedicated to studying honest (e.g., "open-label") placebos. She is published in leading peer-reviewed journals, such as PAIN, the American Journal of Psychiatry, JAMA Psychiatry, and JAMA Pediatrics. Dr. Locher is a co-founder of The Pain Net, an international network of researchers interested in Chronic Primary Pain, including with a special focus on the placebo effect and ethics of placebo and nocebo effects. Her research has been profiled by international news outlets including The Washington Post, The Guardian, and The Sydney Morning Herald. She is one of the co-authors of the upcoming book, The Nocebo Effect: When Words Make You Sick (Mayo Clinic Press / March 19, 2024 / $26.99).https://mcpress.mayoclinic.org/product/the-nocebo-effect/    Dr. Cosima Locher, Ph.D.'s book link: One copy of The Nocebo Effect: When Words Make You Sick (Mayo Clinic Press / March 19, 2024 / $26.99) -- https://www.amazon.com/Nocebo-Effect-When-Words-Make/dp/B0BQR6PLMY    Connect with Dr. Cosima Locher, Ph.D.: Website: https://mcpress.mayoclinic.org/  Facebook: https://www.facebook.com/mayoclinicpress  Instagram: https://www.instagram.com/mayoclinicpress/  LinkedIn: https://www.linkedin.com/company/mayo-clinic-press/  Twitter: https://twitter.com/Mayoclinicpress  YouTube: https://www.youtube.com/channel/UCIZepsWgSHtkO14RAW-_XEg  ***** Hi there! I am Jane Hogan, the Wellness Engineer, and the host of Wellness By Design. I spent 30 years designing foundations for buildings until the pain and inflammation of rheumatoid arthritis led me to hang up my hard hat and follow my heart. Now I blend my backgrounds in science and spirituality to teach people how to tap into the power of their mind, body and soul. I help them release pain naturally so they can become the most wonderful fine version of themselves.    Wellness By Design is a show dedicated to helping people achieve wellness not by reacting to the world around them but by intentionally designing a life based on what their own body needs. In this show we explore practices, methods and science that contribute to releasing pain and inflammation naturally.   Learn more at https://thewellnessengineer.com    Would you like to learn how to release pain by creating more peace and calm?  Download my free guided meditation audio bundle here: https://thewellnessengineer.com/audiobundle    Connect with Jane:  Facebook: https://www.facebook.com/JaneHoganHealth/ Instagram: https://www.instagram.com/janehoganhealth   Janehoganhealthcoach thewellnessengineer  Bewonderfulfine   DISCLAIMER: The information contained in this podcast is for educational purposes only and is not intended to treat, diagnose, cure or prevent any disease. You should always seek the advice of your physician or other qualified healthcare provider with any questions you have regarding a medical condition before undertaking any diet, exercise, supplement, health program, or other procedure discussed in this podcast.

A nationwide shortage of ADHD medication has been limiting the supply of Adderall for almost a year and a half.While the shortage's primary culprit was believed to be supply chain issues, a new study is revealing another cause: an increase in diagnoses among adult women; in fact, the number of women being diagnosed with ADHD has nearly doubled in the last few years.That's according to a new study from JAMA Psychiatry, which revealed prescriptions for ADHD medication have jumped by more than 14% since the start of the pandemic.Read the full story here: https://www.atlantanewsfirst.com/2024/02/19/adhd-diagnoses-increase-adderall-shortage-continues/

Interview with Michael Hollifield, MD, author of Acupuncture for Combat-Related Posttraumatic Stress Disorder: A Randomized Clinical Trial. Hosted by John Torous, MD, MBI. Related Content: Acupuncture for Combat-Related Posttraumatic Stress Disorder

MedLink Neurology Podcast is delighted to feature selected episodes from BrainWaves, courtesy of James E Siegler MD, its originator and host. BrainWaves is an academic audio podcast whose mission is to educate medical providers through clinical cases and topical reviews in neurology, medicine, and the humanities, and episodes originally aired from 2016 to 2021. Originally released: May 10, 2018 There is a nationwide epidemic happening right now. And it's not some terrible virus, it's not because of anything we've had to eat or drink. It is an occupational hazard of the hospital environment: Physician suicide. Dr. Pamela Wible, Founder of the Ideal Medical Care Movement, shares her unique approach to this preventable plague. Produced by James E Siegler. Music by Andrew Sacco, Damiano Baldoni, Kevin McLeod, Jason Shaw, and Rafael Archangel. Voiceover by Patrick Green. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision-making. REFERENCES Goldman ML, Shah RN, Bernstein CA. Depression and suicide among physician trainees: recommendations for a national response. JAMA Psychiatry. 2015 May;72(5):411-2. doi: 10.1001/jamapsychiatry.2014.3050. PMID 25738529Kesselheim AS, Austad KE. Residents: workers or students in the eyes of the law? N Engl J Med 2011;364(8):697-9. PMID 21226569Schernhammer E. Taking their own lives -- the high rate of physician suicide. N Engl J Med 2005;352(24):2473-6. PMID 15958803Schernhammer ES, Colditz GA. Suicide rates among physicians: a quantitative and gender assessment (meta-analysis). Am J Psychiatry 2004;161(12):2295-302. PMID 15569903Sen S, Kranzler HR, Krystal JH, et al. A prospective cohort study investigating factors associated with depression during medical internship. Arch Gen Psychiatry 2010;67(6):557-65. PMID 20368500Witte TK, Fitzpatrick KK, Joiner TE Jr, Schmidt NB. Variability in suicidal ideation: a better predictor of suicide attempts than intensity or duration of ideation? J Affect Disord 2005;88(2):131-6. PMID 16054227  We believe that the principles expressed or implied in the podcast remain valid, but certain details may be superseded by evolving knowledge since the episode's original release date.

In today's episode, we tackle the alarming trend of "swatting," not the buzzing flies kind but the incident where a Black judge, Tanya Chutkan, overseeing a Trump case, experienced an attempted swatting attack at her front door. Unraveling this issue sheds light on the seriousness of such pranks. Next, we dive into comedian Jo Koy's hosting of the Golden Globes. Critics are claiming he didn't do well. Drawing on personal experience as an awards show host, Seales shares her insights and advice in the Am I Trippin segment. In the realm of podcasting, we examine rapper Cam'ron's remarks on racial and ethnic identity, particularly identifying as "Black" versus "African American." A call for unity and acknowledgment of our connectedness forms the basis of this insightful conversation. Switching gears, we explore a concerning study indicating that online racism has detrimental effects on Black youth, potentially leading to symptoms related to post-traumatic stress disorder. This leads to a broader discussion about fostering a positive online environment. W touch on Pope Francis's call for a universal ban on surrogate motherhood, Usher's commitment to a sugar and alcohol-free Super Bowl Halftime Show, and Lisa Bonet filing for divorce from Jason Momoa. In Blackurate News, we highlight the swatting incident involving Judge Tanya Chutkan, Jo Koy's hosting critique, and present the Big Up/Let Down segment. We discuss the unusual but confident pitch from Ja Rule to Nike following their split with Tiger Woods, and a let down to NBA Young Boy for his candid stance on fatherhood. A personal anecdote from hosting the BET Awards in 2020 provides an insider's perspective, and we dive into the Am I Trippin segment featuring a listener's story. The episode wraps up with a Black Pop Quiz, the Word of the Day ("arduous"), and the ever-entertaining Politicians Say the Darndest Things! Listen, Laugh, and Learn on The Amanda Seales Show! FOLLOW ALONG AS WE COVER:   (3:51) - According to a study published in the journal JAMA Psychiatry, Black children and teens who experience racial discrimination online may develop symptoms related to post-traumatic stress disorder. One professor said that Black youth witnessing the evidence of harm being done to Black people either by law enforcement or vigilantes can create a sense of “helplessness or hopelessness” about their future. (8:12) - CAM'RON, the HEY MA rapper turned podcaster recently shared a very bold opinion on how he identifies racially / ethnically. Let's listen. First of all, “Amanda shares thoughts on diaspora war* Here on the Amanda Seales show, we are about fostering PEACE (when appropriate). Let's work out a Black + African TRUCE. peace treaty of sorts, acknowledging how we are CONNECTED, not divided.   (13:01) – 60 Second Headlines Pope Francis has called for a universal ban on what he called the “despicable” practice of surrogate motherhood, including the “commercialization” of pregnancy in an annual speech listing threats to global peace and human dignity. Usher has given up all sugar and alcohol in preparation for his Super Bowl Halftime Show; he says he wants to give the performance of his life. Lisa Bonet has filed for divorce from her husband, Jason Momoa officially; they've been married since 2017 and separated for 2 years. STORY 4: Lastly, Torrei Hart, Kevin Hart‘s ex-wife, announced this week that she will join Katt Williams on the road for his Dark Matter Tour. (16:57) – Why You Bringin' up Old Ish with special guest, Storyteller/Changemaker - Kimberly Renee. (20:58) - COMING UP THIS HOUR IN BLACKURATE NEWS: TANYA CHUTKAN, THE JUDGE OVERSEEING TRUMP'S FEDERAL ELECTION INTERFERENCE CASE, APPEARS TO BE A VICTIM OF SWATTING. I'LL TELL YOU WHAT THAT IS… ALSO, CRITICS ARE SAYING THAT COMEDIAN JO KOY BOMBED AS THE HOST OF THE GOLDEN GLOBES THIS PAST SUNDAY. BUT WHO ARE THE CRITICS THOUGH?! WE'LL WEIGH IN. PLUS, TODAY'S BIG UP/LET DOWN! (22:45) - Police and fire trucks showed up Sunday night at the house of Tanya Chutkan, the federal judge overseeing former President Donald Trump's election interference case after she appeared to be the target of an attempted "swatting" attack. SWATTING - the action or practice of making a prank call to emergency services in an attempt to bring about the dispatch of a large number of armed police officers to a particular address. (26:50) - Comedian Jo Koy is being met with criticism after hosting the Golden Globes. He was hired as the host after other comics, like Chris Rock and Ali Wong, turned it down. Many are accusing him of “bombing,” also known as not being funny. Let's listen to some of his monologue. Here's what Whoopi Goldberg had to say. (32:28) - BIG UP - TO JA RULE'S RELENTLESS CONFIDENCE / UNMITIGATED GALL Nike and Tiger Woods announced their split earlier this week. Ja Rule: “Hey Nike if y'all looking for your new golf sponsorship look no further… Exit Tiger Woods Enter Tiger Hood.” LET DOWN - to NBA YOUNG BOY'S PULL-OUT GAME He said in an interview, “I'm not really big on FATHERHOOD to be honest.” Well get to snipping my brother! The Baton Rouge rapper has 11 kids with eight different women. (35:55) – Amanda shares a story of hosting the BET Awards in 2020. (37:30) - TODAY IS WEDNESDAY, JANUARY 10, 2024.   (39:32) – Am I Trippin' – Amanda will share a story from our listener Keisha, and then share her advice.   (42:21) - Am I Trippin – part 2.. Amanda gives the verdict. Is Keisha trippin?   (46:44) – It's a Black Pop Quiz!   (51:59) - IT'S TIME TO LISTEN LAUGH AND LEARN… I HAVE THE WORD FOR THE DAY…. AND THE WORD OF THE DAY IS…   ARDUOUS (Adjective - AHR-jus-wus) MERRIAM WEBSTER DICTIONARY: DESCRIBES SOMETHING THAT IS VERY DIFFICULT OR STRENUOUS. In a Sentence: Getting people to see the benefit of voting is an arduous task. Once that credit score is down, it's gonna be an arduous task to get it back up!   (54:46) – Politicians Say the Darndest Things!   (58:45) – Thanks for listening!   FOLLOW THE SHOW ON ALL SOCIALS: @Sealessaidit @Amandaseales @Jeremiahlikethebible If You Have A Comment Leave Amanda A Message At 1 855-Amanda-8 That's 1-855-262-6328See omnystudio.com/listener for privacy information.

Interview with Nils R. Winter, MSc, author of A Systematic Evaluation of Machine Learning–Based Biomarkers for Major Depressive Disorder. Hosted by John Torous, MD, MBI. Related Content: A Systematic Evaluation of Machine Learning–Based Biomarkers for Major Depressive Disorder

Interview with Cristiane S. Duarte, PhD, MPH, author of Sociocultural Risk and Resilience in the Context of Adverse Childhood Experiences. Hosted by John Torous, MD, MBI. Related Content: Sociocultural Risk and Resilience in the Context of Adverse Childhood Experiences

Interview with Ulrich Reininghaus, PhD, author of Transdiagnostic Ecological Momentary Intervention for Improving Self-Esteem in Youth Exposed to Childhood Adversity: The SELFIE Randomized Clinical Trial. Hosted by John Torous, MD, MBI. Related Content: Transdiagnostic Ecological Momentary Intervention for Improving Self-Esteem in Youth Exposed to Childhood Adversity

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers the field of critical psychiatry with Dr. Elia Abi-Jaoude and Lucy Costa. Dr. Abi-Jaoude is a staff psychiatrist at The Hospital for Sick Children and Assistant Professor and Clinician Investigator in the Department of Psychiatry at the University of Toronto in Toronto, Canada. Lucy Costa is Deputy Executive Director of the Empowerment Council, a voice for clients of mental health and addiction services primarily at the Centre for Addiction and Mental Health in Toronto.   While this topic could be very philosophical and expansive, we are going to focus our discussion by considering the practical implications of this field on psychiatric practice. What do you need to know about critical psychiatry as a trainee, and how might it impact your clinical practice?   The learning objectives for this episode are as follows: By the end of this episode, the listener will be able to… Define the term critical psychiatry and describe how the field has evolved over time Review core principles of critical psychiatry and apply them to a clinical situation Understand the potential benefits and harms of critical psychiatry and where the field is headed   Guests: Dr. Eila Abi-Jaoude and Lucy Costa   Hosts: Dr. Gaurav Sharma (PGY5), Dr. Nikhita Singhal (PGY5), Dr. Monisha Basu (PGY2), and Saja Jaberi (IMG)   Audio editing by: Gaurav Sharma   Show notes by: Gaurav Sharma and Nikhita Singhal   Conflicts of interest: Neither of our guests nor hosts have declared any conflicts of interest related to this topic. Interview content: Introduction - 00:13 Learning objectives - 02:35 Defining critical psychiatry - 03:33 How our experts got involved in critical psychiatry and incorporate it into their work - 04:50 What are some of the questions critical psychiatry tries to answer? - 15:07 Why care about critical psychiatry and “holding truths lightly”? - 23:55 Principles of critical psychiatry - 24:55 Applying critical psychiatry principles to a case - 32:40 Potential benefits and harms of a critical psychiatry approach - 41:49 Future directions for critical psychiatry - 58:29 Review of learning objectives and summary - 1:01:30 End credits - 1:03:17   Resources: Critical Psychiatry Textbook Restoring Study 329  Psych Debate 14 | Critical Psychiatry and Diagnosis   References: Barkil-Oteo A. Collaborative care for depression in primary care: how psychiatry could "troubleshoot" current treatments and practices. Yale J Biol Med. 2013 Jun 13;86(2):139-46. Craddock N, Mynors-Wallis L. Psychiatric diagnosis: impersonal, imperfect and important. The British Journal of Psychiatry. 2014;204(2):93-95. doi:10.1192/bjp.bp.113.133090 Kirsch I. The emperor's new drugs: medication and placebo in the treatment of depression. Handb Exp Pharmacol. 2014;225:291-303. doi:10.1007/978-3-662-44519-8_16 Middleton H, Moncrieff J. Critical psychiatry: a brief overview. BJPsych Advances. 2019;25(1):47-54. doi:10.1192/bja.2018.38 O'Donoghue T, Crossley J. A critical narrative analysis of psychiatrists' engagement with psychosis as a contentious area. Int J Soc Psychiatry. 2020 Nov;66(7):724-730. doi: 10.1177/0020764020934516 Samara MT, Dold M, Gianatsi M, et al. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. JAMA Psychiatry. 2016;73(3):199–210. doi:10.1001/jamapsychiatry.2015.2955   Important figures in the history of anti-psychiatry and critical psychiatry (discussion edited from episode for length): Anti-Psychiatrists: R. D. Laing (UK) Thomas Szasz (USA) Michel Foucault (France)   Critical Psychiatrists: Joanna Moncrieff (UK) Suman Fernando (UK) Sami Tamini (UK) Pat Bracken (UK) Derek Summerfield (UK) Sandra Steinguard (USA) Critical Psychiatry Network  (International Email List)   For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.